Pembrolizumab in Ultramutated and Hypermutated Endometrial Cancer
Clinical trial NCT02899793 · COMPLETED
Trial details
- NCT number
- NCT02899793
- Sponsor
- Yale University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2024-07-17
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.